Alan T N Tita1, Yinglei Lai, Mark B Landon, Catherine Y Spong, Kenneth J Leveno, Michael W Varner, Steve N Caritis, Paul J Meis, Ronald J Wapner, Yoram Sorokin, Alan M Peaceman, Mary J O'Sullivan, Baha M Sibai, John M Thorp, Susan M Ramin, Brian M Mercer. 1. From the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham, Birmingham Alabama; The Ohio State University, Columbus, Ohio; University of Texas Southwestern Medical Center, Dallas, Texas; University of Utah, Salt Lake City, Utah; University of Pittsburgh, Pittsburgh, Pennsylvania; Wake Forest University Health Sciences, Winston-Salem, North Carolina; Thomas Jefferson University, Philadelphia, Pennsylvania; Wayne State University, Detroit, Michigan; Northwestern University, Chicago, Illinois; University of Miami, Miami, Florida; University of Tennessee, Memphis, Tennessee; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; University of Texas Health Science Center at Houston, Houston, Texas; Case Western Reserve University-MetroHealth Medical Center, Cleveland, Ohio; and The George Washington University Biostatistics Center, Washington, DC, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.
Abstract
OBJECTIVE: Elective repeat cesarean delivery at 37 or 38 weeks compared with 39 completed weeks of gestation is associated with adverse neonatal outcomes. We assessed whether delivery before 39 weeks is justifiable on the basis of decreased adverse maternal outcomes. METHODS: We conducted a cohort study of women with live singleton pregnancies delivered by prelabor elective repeat cesarean delivery from 1999 through 2002 at 19 U.S. academic centers. Gestational age was examined by completed weeks (eg, 37 completed weeks=37 0/7-37 6/7 weeks). Maternal outcomes included a primary composite of death, hysterectomy, uterine rupture or dehiscence, blood transfusion, uterine atony, thromboembolic complications, anesthetic complications, surgical injury or need for arterial ligation, intensive care unit admission, wound complications, or endometritis. RESULTS: Of 13,258 elective repeat cesareans performed at 37 weeks of gestation or later, 11,255 (84.9%) were between 37 0/7 and 39 6/7 weeks (6.3% at 37, 29.5% at 38, and 49.1% at 39 completed weeks), and 15.1% were at 40 0/7 weeks or more. The primary outcome occurred in 7.43% at 37 weeks, 7.47% at 38 weeks and 6.56% at 39 weeks (P for trend test=.09). Delivery before 39 weeks was not associated with a decrease in the primary outcome when compared with delivery at 39 weeks (adjusted odds ratio 1.16; 95% confidence interval 1.00-1.34). Early delivery was associated with increased maternal hospitalization of 5 days or more [1.96 (1.54, 2.49)] but not with a composite of death or hysterectomy or with individual maternal morbidities. CONCLUSION: Elective repeat cesarean delivery at 37 or 38 weeks is not associated with decreased maternal morbidity. LEVEL OF EVIDENCE: II.
OBJECTIVE: Elective repeat cesarean delivery at 37 or 38 weeks compared with 39 completed weeks of gestation is associated with adverse neonatal outcomes. We assessed whether delivery before 39 weeks is justifiable on the basis of decreased adverse maternal outcomes. METHODS: We conducted a cohort study of women with live singleton pregnancies delivered by prelabor elective repeat cesarean delivery from 1999 through 2002 at 19 U.S. academic centers. Gestational age was examined by completed weeks (eg, 37 completed weeks=37 0/7-37 6/7 weeks). Maternal outcomes included a primary composite of death, hysterectomy, uterine rupture or dehiscence, blood transfusion, uterine atony, thromboembolic complications, anesthetic complications, surgical injury or need for arterial ligation, intensive care unit admission, wound complications, or endometritis. RESULTS: Of 13,258 elective repeat cesareans performed at 37 weeks of gestation or later, 11,255 (84.9%) were between 37 0/7 and 39 6/7 weeks (6.3% at 37, 29.5% at 38, and 49.1% at 39 completed weeks), and 15.1% were at 40 0/7 weeks or more. The primary outcome occurred in 7.43% at 37 weeks, 7.47% at 38 weeks and 6.56% at 39 weeks (P for trend test=.09). Delivery before 39 weeks was not associated with a decrease in the primary outcome when compared with delivery at 39 weeks (adjusted odds ratio 1.16; 95% confidence interval 1.00-1.34). Early delivery was associated with increased maternal hospitalization of 5 days or more [1.96 (1.54, 2.49)] but not with a composite of death or hysterectomy or with individual maternal morbidities. CONCLUSION: Elective repeat cesarean delivery at 37 or 38 weeks is not associated with decreased maternal morbidity. LEVEL OF EVIDENCE: II.
Authors: Alan T N Tita; Mark B Landon; Catherine Y Spong; Yinglei Lai; Kenneth J Leveno; Michael W Varner; Atef H Moawad; Steve N Caritis; Paul J Meis; Ronald J Wapner; Yoram Sorokin; Menachem Miodovnik; Marshall Carpenter; Alan M Peaceman; Mary J O'Sullivan; Baha M Sibai; Oded Langer; John M Thorp; Susan M Ramin; Brian M Mercer Journal: N Engl J Med Date: 2009-01-08 Impact factor: 91.245
Authors: Catherine Y Spong; Mark B Landon; Sharon Gilbert; Dwight J Rouse; Kenneth J Leveno; Michael W Varner; Atef H Moawad; Hyagriv N Simhan; Margaret Harper; Ronald J Wapner; Yoram Sorokin; Menachem Miodovnik; Marshall Carpenter; Alan M Peaceman; Mary J O'Sullivan; Baha M Sibai; Oded Langer; John M Thorp; Susan M Ramin; Brian M Mercer Journal: Obstet Gynecol Date: 2007-10 Impact factor: 7.661
Authors: Alan Thevenet N Tita; Yinglei Lai; Steven L Bloom; Catherine Y Spong; Michael W Varner; Susan M Ramin; Steve N Caritis; William A Grobman; Yoram Sorokin; Anthony Sciscione; Marshall W Carpenter; Brian M Mercer; John M Thorp; Fergal D Malone; Margaret Harper; Jay D Iams Journal: Am J Obstet Gynecol Date: 2011-12-16 Impact factor: 8.661
Authors: Alan T N Tita; Kathleen A Jablonski; Jennifer L Bailit; William A Grobman; Ronald J Wapner; Uma M Reddy; Michael W Varner; John M Thorp; Kenneth J Leveno; Steve N Caritis; Jay D Iams; George Saade; Yoram Sorokin; Dwight J Rouse; Sean C Blackwell; Jorge E Tolosa Journal: Am J Obstet Gynecol Date: 2018-05-22 Impact factor: 8.661
Authors: Beth A Plunkett; Grecio Sandoval; Jennifer L Bailit; Uma M Reddy; Ronald J Wapner; Michael W Varner; John M Thorp; Steve N Caritis; Mona Prasad; Alan T N Tita; George R Saade; Yoram Sorokin; Dwight J Rouse; Sean C Blackwell; Jorge E Tolosa Journal: Obstet Gynecol Date: 2019-09 Impact factor: 7.623
Authors: Seung Mi Lee; Joong Shin Park; Young Mi Jung; Su Ah Kim; Ji Hyun Ahn; Jina Youm; Chan Wook Park; Jong Kwan Jun Journal: J Korean Med Sci Date: 2018-02-12 Impact factor: 2.153
Authors: Freke A Wilmink; Clarabelle T Pham; Nicole Edge; Chantal W P M Hukkelhoven; Eric A P Steegers; Ben W Mol Journal: Aust N Z J Obstet Gynaecol Date: 2018-04-26 Impact factor: 2.100
Authors: Christine L Roberts; Michael C Nicholl; Charles S Algert; Jane B Ford; Jonathan M Morris; Jian Sheng Chen Journal: BMC Pregnancy Childbirth Date: 2014-04-03 Impact factor: 3.007